Ovid Application Error
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy. Akalu, Yemsratch T. 1; Rothlin, Carla V. *,1,2; Ghosh, Sourav *,2,3 [Review] Immunological Reviews. 276(1):165-177, March 2017.
(Format: HTML, PDF)